1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Current knowledge in genetics, molecular diagnostic tools, and treatments for mantle cell lymphomas
    Review

    Sethi, S.; Epstein-Peterson, Z.; Kumar, A.; Ho, C.
    Frontiers in Oncology (2021)

    Fulltext@MSK | Save
  • Durable response to brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone (BV-CHP) in a patient with CD30-positive PTCL arising as a post-transplant lymphoproliferative disorder (PTLD)
    Journal Article

    Hong, J.; Johnson, W. T.; Kartan, S.; Gonsalves, A. S.; Fenkel, J. M.; Gong, J. Z.; Porcu, P.
    Current Oncology (2021)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance and COVID-19: A population-based cohort study
    Journal Article

    Rognvaldsson, S.; Eythorsson, E.; Thorsteinsdottir, S.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; ThorsteinsdoĢttir, I.; Olafsson, I.; Runolfsdottir, H. L.; more...
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • CNS involvement in AML at diagnosis is rare and does not affect response or survival: Data from 11 ECOG-ACRIN trials
    Journal Article

    Ganzel, C.; Lee, J. W.; Fernandez, H. F.; Paietta, E. M.; Luger, S. M.; Lazarus, H. M.; Cripe, L. D.; Douer, D.; Wiernik, P. H.; Rowe, J. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Successful incorporation of electronic patient-reported outcomes using PROMIS-29 into standard of care for lymphoma patients receiving CD19-directed chimeric antigen receptor T (CAR T) cell therapy
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Sauter, C.; Batlevi, C.; Dahi, P. B.; Lin, R.; Palomba, M. L.; Perales, M. A.; Giralt, S. A.
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • Using PROMIS-preference (PROPr) scores to measure changes in quality of life after tyrosine kinase inhibitor discontinuation
    Meeting Abstract

    Winn, A.; Atallah, E.; Lin, L.; Thompson, J.; Moore, J.; Larson, R.; Cortes, J.; Mauro, M.; Pinilla, J.; Flynn, K.
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • Trajectories of symptom and quality-of-life (QOL) recovery after autologous stem cell transplantation (ASCT) in multiple myeloma (MM): Secondary analysis of BMT CTN 0702 trial
    Meeting Abstract

    D'Souza, A.; Brazauskas, R.; Stadtmauer, E.; Pasquini, M.; Hari, P.; Bashey, A.; Devine, S.; Efeberra, Y.; Ganguly, S.; Gasparetto, C.; more...
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia
    Meeting Abstract

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • A phase 2 multicenter study of Iovance autologous tumor infiltrating lymphocytes (TIL, LN-145) cell therapy in patients with metastatic NSCLC
    Meeting Abstract

    Massarelli, E.; Schoenfeld, A.; Chesney, J.; Hong, Y.; Lammers, P.; Nieva, J.; Wise-Draper, T.; Goldberg, Z.; Cacovean, A.; Yadav, B.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Phase 2, study of Iovance autologous tumor infiltrating lymphocytes (Lifileucel, LN-144, LN-145, LN-145-S1) in patients with solid tumors
    Meeting Abstract

    Gettinger, S.; Kluger, H.; Schoenfeld, A.; Betof Warner, A.; He, K.; Sukari, A.; Thomas, S.; Doger, B.; Lee, S.; Haefliger, S.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save